{
  "study_design": {
    "type": "single-center, real-world study",
    "population": "104 patients with first-diagnosed idiopathic dilated cardiomyopathy (DCM)",
    "setting": "Sun Yat-sen Memorial Hospital, Sun Yat-sen University",
    "duration": "January 2014 to December 2017 for patient data collection with follow-up until December 2018",
    "variables_measured": [
      "left ventricular ejection fraction (LVEF)",
      "left ventricular end-diastolic diameter (LVDd)",
      "right ventricular end-diastolic dimension",
      "high-density lipoprotein cholesterol (HDL-C)",
      "cystatin C",
      "systolic blood pressure",
      "severe mitral regurgitation",
      "eGFR",
      "NYHA classification"
    ],
    "outcome": {
      "LVRR": "Defined as an absolute increase in LVEF from >10% to a final value >35% and a decrease in LVDd >10%",
      "non-LVRR": "Defined as an absolute increase in LVEF <10%, final value <35%, or a decrease in LVDd <10%"
    },
    "models_compared": [
      "logistic regression",
      "random forests",
      "extreme gradient boosting (XGBoost)"
    ],
    "evaluation_method": "10-fold cross-validation with ROC curves and calibration plot for performance evaluation",
    "controls": "Not explicitly mentioned",
    "significant_findings": "XGBoost outperformed other models in predicting LVRR with higher AU-ROC"
  }
}